Literature DB >> 25244353

Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.

C Kellner1, S Bauriedl, S Hollstein, U Reinhold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25244353     DOI： 10.1111/bjd.13420

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  [Daylight photodynamic therapy : Back to the future?]

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

2.  [Decision criteria and patient characteristics for patient-oriented treatment of field cancerization : Standardized algorithm for personalized treatment concepts].

Authors:  W G Philipp-Dormston; R Aschoff; T von Braunmühl; T Eigentler; T Haalck; K-M Thoms
Journal:  Hautarzt       Date:  2021-04       Impact factor: 0.751

3.  Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis.

Authors:  Mariachiara Arisi; Benedetta Galli; Edoardo Guasco Pisani; Giuseppe La Rosa; Gaetano Licata; Sara Rovaris; Cesare Tomasi; Mariateresa Rossi; Marina Venturini; Luigi Spiazzi; PierGiacomo Calzavara-Pinton
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-30

4.  Alternatives to Outdoor Daylight Illumination for Photodynamic Therapy--Use of Greenhouses and Artificial Light Sources.

Authors:  Catharina M Lerche; Ida M Heerfordt; Jakob Heydenreich; Hans Christian Wulf
Journal:  Int J Mol Sci       Date:  2016-02-29       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.